Navigation Links
Holy Name Medical Center Treats Migraine Headaches At Dedicated Center
Date:5/29/2013

TEANECK, N.J., May 29, 2013 /PRNewswire/ -- Holy Name Medical Center has established a Headache Treatment Program for the care of adults, adolescents and children who suffer from intractable migraine headaches, and for whom conventional methods of therapy have failed. Holy Name neurologist James Charles , MD, FAAN, FAHS, is medical director of the Headache Treatment Program, and is certified in headache medicine by the United Council of Neurologic Subspecialties.

Under the direction of staff neurologists, intravenous medications are administered on an outpatient basis by nursing staff specially trained in the field of headache medicine to ensure maximum safety and effectiveness. Children and teens are treated on the Medical Center's pediatric and young adult floor; adults are treated in the adult infusion center. Most patients require one visit; others may need repetitive, daily treatment for up to three days. Holy Name is the only facility in New Jersey offering infusion therapies to intractable headache patients of all ages.

Early intervention can re-set the brain's headache mechanism

"Studies have demonstrated that, with early intervention, as soon as the patient is identified and that patient is placed onto an appropriate treatment program, the transformation to the malignant, disabling forms of migraine can be prevented," explains Dr. Charles.  "This is a biological disease that is often genetic. A migraine attack lowers the threshold for more brain attacks. More brain attacks cause anatomic and functional alterations of the brain, setting the stage for more frequent and debilitating migraine headaches."

According to Dr. Charles, infusion therapy is highly effective for patients with:

  • chronic migraines with and without medication overuse, who have failed multiple treatments to prevent or stop migraine symptoms, and who are disabled by their headaches but do not require or desire inpatient treatment
  • migraine headaches lasting longer than 72 hours and that do not respond to conventional medications
  • acute migraine attacks that last fewer than 72 hours, are debilitating, and not responsive to self-administered medications
  • prolonged aura
  • cluster headache exacerbation
  • new, daily persistent headache

"While most patients experience relief after an outpatient treatment," continues Dr. Charles, "there are those whose headache attack will not terminate after days and weeks, and there are some chronic migraine patients whose headaches do not respond to oral medications.  The Headache Treatment Program at Holy Name is designed for such patients. Children, teenagers, and adults are treated with the appropriate medications to break the vicious headache cycle, and leave our infusion center feeling better. The long-term goal is to reset the brain's neurochemistry so that, in conjunction with targeted outpatient treatment, patients can go from frequent severe headaches to minimal headaches."

"Lowering the burden of migraine starts with educating the public, especially parents and teachers," notes Dr. Charles. "It is a misconception that an acute headache with nausea, vomiting, and the need for bed rest is due to conditions such as sinusitis, eyestrain or dental problems."

Facts & Stats About Migraine Headache

  • The World Health Organization has placed migraine in the top 20 group of most disabling diseases of the world. 
  • In the United States, there are 28 million people over the age of 12 who suffer with migraines.
  • In the US, there are eight million children under the age of 12 who suffer with migraines.
  • Thirty percent of migraine sufferers never see a doctor because they have low-frequency intermittent headaches, experience occasional headaches, and do not require medical assistance.
  • Seventy percent of migraine sufferers fall into one of two categories: About 40% will have intermediate to high-frequency migraine attacks. The remaining 30% will transform to chronic migraine which is defined as more than 15 headache days per month.
  • Chronic migraine patients (adults and children) have decreased academic performance, impaired work productivity, and can become socially withdrawn. 

For more information about migraine headache or the Headache Treatment Program at Holy Name Medical Center, patients may contact Holy Name's Call Center at 1-877-HOLY-NAME.

ABOUT HOLY NAME MEDICAL CENTER:
Holy Name Medical Center is a fully accredited, not-for-profit healthcare facility based in Teaneck, New Jersey, with off-site locations throughout Bergen County.  Founded and sponsored by the Sisters of St. Joseph of Peace in 1925, the comprehensive 361-bed medical center offers leading-edge medical practice and technology administered in an environment rooted in a tradition of compassion and respect for every patient. Holy Name provides high quality health care across a continuum that encompasses education, prevention, early intervention, comprehensive treatment options, rehabilitation and wellness maintenance—from pre-conception through end-of-life.


'/>"/>
SOURCE Holy Name Medical Center
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... , January 19, 2017 According to a ... cryotherapy is set to witness a CAGR of 6.5% during the ... will continue to be the leading market for cryotherapy ... ... are emphasizing on ensuring affordable and adequate supply of gas in ...
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... In 2009, Carol Bryan ... resulted in severe facial disfiguration. After four frightening years of isolation and emotional ... Medical Center, who removed the substances in a partial facial transplant through eight ...
(Date:1/19/2017)... ... January 19, 2017 , ... Workrite Ergonomics announced this ... The Tranquility privacy panel system was designed to deliver the ideal blend of ... noise and provide the visual privacy required to maintain concentration levels and increase ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... Sam ... planning assistance to commercial and residential clients in the California Bay Area, is launching ... heart health in the region. , Heart disease is the primary killer of adult ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... which serves Lawrenceville, New Jersey and the surrounding area, is inaugurating a ... sclerosis (ALS), more commonly known as Lou Gehrig's disease or motor neurone disease, ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Spring Create Real Impact contest from Impact Teen Drivers and California Casualty. Entries ... . , Educational grants totaling $15,000 will be awarded for the best ...
Breaking Medicine News(10 mins):